vision-restoration

Ray Therapeutics is a clinical-stage biotechnology company developing optogenetic, gene-based medicines to restore vision in people with blinding degenerative retinal diseases. Its approach reprograms surviving retinal neurons to detect light and transmit visual signals to the brain, independent of the underlying gene mutation.

RhyGaze is a clinical-stage biotechnology company developing gene therapy treatments to restore vision for people with retinal degenerative diseases. Its platform combines optogenetic proteins that engineer photosensitivity into mammalian cells with gene therapy delivery tools that install light-sensing machinery into human eye cells, technology…